Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Zepbound and Mounjaro (tirzepatide): why the FDA put a warning on the label Tirzepatide has 2 active ingredients: GLP-1 / GIP dual agonists and the FDA labels for both Mounjaro (the diabetes formulation) and Zepbound (the chronic-weight-management formulation) carry an explicit drug-interaction note about oral hormonal contraceptives
Key facts Apotex authorization: May 1, 2026 [Source: canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html] Expected launch: within weeks, per Apotex VP Catherine Thomas [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915] Other reviews: seven additional generic semaglutide submissions under Health Canada review [Source: canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html] This article is for informational purposes only and does not constitute medical advice
Your first pen may contain up to six doses
Our treatments are tailored to your specific metabolic profile, ensuring that your dosage is optimized for both weight loss and comfort
The molecule is designed to be stable at room temperature, but for long-term storage, it is recommended to keep it refrigerated
Victoza (Liraglutide) Injection, for Subcutaneous Use: Prescribing Information
